25 XP   0   0   10

Ypsomed Holding AG
Buy, Hold or Sell?

Let's analyse Ypsomed together

PenkeI guess you are interested in Ypsomed Holding AG. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Ypsomed Holding AG. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Ypsomed Holding AG

I send you an email if I find something interesting about Ypsomed Holding AG.

Quick analysis of Ypsomed (30 sec.)










What can you expect buying and holding a share of Ypsomed? (30 sec.)

How much money do you get?

How much money do you get?
CHF4.65
When do you have the money?
1 year
How often do you get paid?
97.4%

What is your share worth?

Current worth
CHF42.58
Expected worth in 1 year
CHF48.94
How sure are you?
92.3%

+ What do you gain per year?

Total Gains per Share
CHF10.60
Return On Investment
3.1%

For what price can you sell your share?

Current Price per Share
CHF337.50
Expected price per share
CHF295.00 - CHF389.50
How sure are you?
50%

1. Valuation of Ypsomed (5 min.)




Live pricePrice per Share (EOD)

CHF337.50

Intrinsic Value Per Share

CHF-27.24 - CHF-2.22

Total Value Per Share

CHF15.34 - CHF40.36

2. Growth of Ypsomed (5 min.)




Is Ypsomed growing?

Current yearPrevious yearGrowGrow %
How rich?$636.3m$502.1m$138.1m21.6%

How much money is Ypsomed making?

Current yearPrevious yearGrowGrow %
Making money$32.9m$12.9m$20m60.9%
Net Profit Margin14.2%4.8%--

How much money comes from the company's main activities?

3. Financial Health of Ypsomed (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#54 / 169

Most Revenue
#44 / 169

Most Profit
#37 / 169

What can you expect buying and holding a share of Ypsomed? (5 min.)

Welcome investor! Ypsomed's management wants to use your money to grow the business. In return you get a share of Ypsomed.

What can you expect buying and holding a share of Ypsomed?

First you should know what it really means to hold a share of Ypsomed. And how you can make/lose money.

Speculation

The Price per Share of Ypsomed is CHF337.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ypsomed.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ypsomed, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is CHF42.58. Based on the TTM, the Book Value Change Per Share is CHF1.59 per quarter. Based on the YOY, the Book Value Change Per Share is CHF2.41 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is CHF1.06 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ypsomed.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 CHF% of Price per ShareCHF% of Price per ShareCHF% of Price per ShareCHF% of Price per ShareCHF% of Price per Share
Usd Eps2.930.9%2.420.7%0.630.2%0.690.2%0.750.2%
Usd Book Value Change Per Share0.870.3%1.740.5%2.640.8%0.870.3%0.740.2%
Usd Dividend Per Share1.420.4%1.160.3%0.160.0%0.490.1%0.420.1%
Usd Total Gains Per Share2.300.7%2.900.9%2.800.8%1.360.4%1.170.3%
Usd Price Per Share295.08-230.18-171.68-166.76-156.33-
Price to Earnings Ratio25.14-25.20-68.00-112.21-84.01-
Price-to-Total Gains Ratio128.56--75.47-62.64-321.54-422.53-
Price to Book Ratio6.33-4.92-4.83-4.88-5.69-
Price-to-Total Gains Ratio128.56--75.47-62.64-321.54-422.53-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share369.52875
Number of shares2
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share1.160.49
Usd Book Value Change Per Share1.740.87
Usd Total Gains Per Share2.901.36
Gains per Quarter (2 shares)5.802.71
Gains per Year (2 shares)23.2110.85
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
191413471
219283681412
3284259122123
4375682162834
54670105203545
65683128244256
76597151274867
874111174315578
984125197356289
10931392203969100

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.00.00.0100.0%11.00.00.0100.0%19.00.00.0100.0%39.00.00.0100.0%87.00.00.0100.0%
Book Value Change Per Share2.01.00.066.7%6.03.02.054.5%8.05.06.042.1%18.07.014.046.2%21.012.054.024.1%
Dividend per Share2.00.01.066.7%10.00.01.090.9%18.00.01.094.7%38.00.01.097.4%46.00.041.052.9%
Total Gains per Share2.01.00.066.7%8.03.00.072.7%16.03.00.084.2%36.03.00.092.3%45.06.036.051.7%

Fundamentals of Ypsomed

About Ypsomed Holding AG

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.

Fundamental data was last updated by Penke on 2024-04-26 00:34:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Ypsomed Holding AG.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Ypsomed earns for each CHF1 of revenue.

  • Above 10% is considered healthy but always compare Ypsomed to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 14.3% means that CHF0.14 for each CHF1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ypsomed Holding AG:

  • The MRQ is 14.3%. The company is making a huge profit. +2
  • The TTM is 14.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ14.3%TTM14.2%+0.1%
TTM14.2%YOY4.8%+9.4%
TTM14.2%5Y6.3%+7.9%
5Y6.3%10Y8.0%-1.6%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ14.3%6.2%+8.1%
TTM14.2%6.2%+8.0%
YOY4.8%8.0%-3.2%
5Y6.3%7.3%-1.0%
10Y8.0%6.8%+1.2%
1.1.2. Return on Assets

Shows how efficient Ypsomed is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ypsomed to the Medical Instruments & Supplies industry mean.
  • 3.9% Return on Assets means that Ypsomed generated CHF0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ypsomed Holding AG:

  • The MRQ is 3.9%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.9%TTM3.4%+0.5%
TTM3.4%YOY1.5%+1.9%
TTM3.4%5Y1.5%+1.9%
5Y1.5%10Y1.8%-0.3%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ3.9%1.2%+2.7%
TTM3.4%1.3%+2.1%
YOY1.5%1.9%-0.4%
5Y1.5%2.2%-0.7%
10Y1.8%2.0%-0.2%
1.1.3. Return on Equity

Shows how efficient Ypsomed is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ypsomed to the Medical Instruments & Supplies industry mean.
  • 6.4% Return on Equity means Ypsomed generated CHF0.06 for each CHF1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ypsomed Holding AG:

  • The MRQ is 6.4%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 5.1%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ6.4%TTM5.1%+1.3%
TTM5.1%YOY2.6%+2.5%
TTM5.1%5Y2.4%+2.7%
5Y2.4%10Y2.8%-0.4%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ6.4%2.5%+3.9%
TTM5.1%2.7%+2.4%
YOY2.6%3.7%-1.1%
5Y2.4%3.9%-1.5%
10Y2.8%3.8%-1.0%

1.2. Operating Efficiency of Ypsomed Holding AG.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Ypsomed is operating .

  • Measures how much profit Ypsomed makes for each CHF1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ypsomed to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 14.3% means the company generated CHF0.14  for each CHF1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ypsomed Holding AG:

  • The MRQ is 14.3%. The company is operating less efficient.
  • The TTM is 10.7%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ14.3%TTM10.7%+3.7%
TTM10.7%YOY5.3%+5.4%
TTM10.7%5Y5.9%+4.7%
5Y5.9%10Y8.8%-2.9%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ14.3%8.1%+6.2%
TTM10.7%7.6%+3.1%
YOY5.3%10.9%-5.6%
5Y5.9%10.1%-4.2%
10Y8.8%10.5%-1.7%
1.2.2. Operating Ratio

Measures how efficient Ypsomed is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 0.86 means that the operating costs are CHF0.86 for each CHF1 in net sales.

Let's take a look of the Operating Ratio trends of Ypsomed Holding AG:

  • The MRQ is 0.857. The company is less efficient in keeping operating costs low.
  • The TTM is 0.870. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.857TTM0.870-0.014
TTM0.870YOY0.699+0.171
TTM0.8705Y0.697+0.173
5Y0.69710Y0.766-0.069
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8571.153-0.296
TTM0.8701.168-0.298
YOY0.6991.105-0.406
5Y0.6971.097-0.400
10Y0.7661.056-0.290

1.3. Liquidity of Ypsomed Holding AG.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Ypsomed is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 0.77 means the company has CHF0.77 in assets for each CHF1 in short-term debts.

Let's take a look of the Current Ratio trends of Ypsomed Holding AG:

  • The MRQ is 0.773. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.794. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.773TTM0.794-0.021
TTM0.794YOY0.770+0.024
TTM0.7945Y0.751+0.043
5Y0.75110Y0.915-0.163
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7732.302-1.529
TTM0.7942.333-1.539
YOY0.7702.588-1.818
5Y0.7512.627-1.876
10Y0.9152.623-1.708
1.3.2. Quick Ratio

Measures if Ypsomed is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ypsomed to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.41 means the company can pay off CHF0.41 for each CHF1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ypsomed Holding AG:

  • The MRQ is 0.410. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.468. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.410TTM0.468-0.058
TTM0.468YOY0.415+0.053
TTM0.4685Y0.393+0.075
5Y0.39310Y0.392+0.001
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4101.117-0.707
TTM0.4681.127-0.659
YOY0.4151.306-0.891
5Y0.3931.430-1.037
10Y0.3921.533-1.141

1.4. Solvency of Ypsomed Holding AG.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Ypsomed assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ypsomed to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.38 means that Ypsomed assets are financed with 38.0% credit (debt) and the remaining percentage (100% - 38.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ypsomed Holding AG:

  • The MRQ is 0.380. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.339. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.380TTM0.339+0.040
TTM0.339YOY0.409-0.069
TTM0.3395Y0.408-0.068
5Y0.40810Y0.364+0.044
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3800.357+0.023
TTM0.3390.360-0.021
YOY0.4090.353+0.056
5Y0.4080.365+0.043
10Y0.3640.371-0.007
1.4.2. Debt to Equity Ratio

Measures if Ypsomed is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ypsomed to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 62.0% means that company has CHF0.62 debt for each CHF1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ypsomed Holding AG:

  • The MRQ is 0.620. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.503. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.620TTM0.503+0.116
TTM0.503YOY0.695-0.191
TTM0.5035Y0.698-0.195
5Y0.69810Y0.586+0.112
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6200.541+0.079
TTM0.5030.561-0.058
YOY0.6950.551+0.144
5Y0.6980.651+0.047
10Y0.5860.670-0.084

2. Market Valuation of Ypsomed Holding AG

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every CHF1 in earnings Ypsomed generates.

  • Above 15 is considered overpriced but always compare Ypsomed to the Medical Instruments & Supplies industry mean.
  • A PE ratio of 25.14 means the investor is paying CHF25.14 for every CHF1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ypsomed Holding AG:

  • The EOD is 31.483. Based on the earnings, the company is overpriced. -1
  • The MRQ is 25.140. Based on the earnings, the company is overpriced. -1
  • The TTM is 25.202. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD31.483MRQ25.140+6.343
MRQ25.140TTM25.202-0.062
TTM25.202YOY67.999-42.798
TTM25.2025Y112.213-87.011
5Y112.21310Y84.009+28.204
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD31.48314.387+17.096
MRQ25.14015.934+9.206
TTM25.20216.425+8.777
YOY67.99921.990+46.009
5Y112.21320.830+91.383
10Y84.00924.796+59.213
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ypsomed Holding AG:

  • The EOD is -69.736. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -55.686. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.858. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-69.736MRQ-55.686-14.051
MRQ-55.686TTM-2.858-52.827
TTM-2.858YOY57.756-60.615
TTM-2.8585Y4.736-7.594
5Y4.73610Y16.570-11.833
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-69.7369.339-79.075
MRQ-55.6868.949-64.635
TTM-2.8581.445-4.303
YOY57.7563.453+54.303
5Y4.7365.897-1.161
10Y16.570-0.032+16.602
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Ypsomed is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 6.33 means the investor is paying CHF6.33 for each CHF1 in book value.

Let's take a look of the Price to Book Ratio trends of Ypsomed Holding AG:

  • The EOD is 7.926. Based on the equity, the company is overpriced. -1
  • The MRQ is 6.329. Based on the equity, the company is overpriced. -1
  • The TTM is 4.918. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD7.926MRQ6.329+1.597
MRQ6.329TTM4.918+1.411
TTM4.918YOY4.831+0.088
TTM4.9185Y4.881+0.038
5Y4.88110Y5.693-0.812
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD7.9262.416+5.510
MRQ6.3292.753+3.576
TTM4.9182.692+2.226
YOY4.8313.294+1.537
5Y4.8813.659+1.222
10Y5.6934.236+1.457
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Ypsomed Holding AG compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.7961.589-50%2.410-67%0.790+1%0.679+17%
Book Value Per Share--42.58142.846-1%33.605+27%31.442+35%25.832+65%
Current Ratio--0.7730.794-3%0.770+0%0.751+3%0.915-15%
Debt To Asset Ratio--0.3800.339+12%0.409-7%0.408-7%0.364+4%
Debt To Equity Ratio--0.6200.503+23%0.695-11%0.698-11%0.586+6%
Dividend Per Share--1.3001.061+23%0.150+766%0.448+190%0.388+235%
Eps--2.6802.206+21%0.576+366%0.633+324%0.688+290%
Free Cash Flow Per Share---1.210-0.844-30%-0.028-98%-0.981-19%-0.149-88%
Free Cash Flow To Equity Per Share--0.860-0.620+172%0.455+89%0.001+90824%0.231+273%
Gross Profit Margin---0.025-0.107+323%-0.691+2643%-0.992+3834%-0.801+3078%
Intrinsic Value_10Y_max---2.224--------
Intrinsic Value_10Y_min---27.238--------
Intrinsic Value_1Y_max---0.542--------
Intrinsic Value_1Y_min---1.643--------
Intrinsic Value_3Y_max---1.385--------
Intrinsic Value_3Y_min---5.908--------
Intrinsic Value_5Y_max---1.935--------
Intrinsic Value_5Y_min---11.202--------
Market Cap4606436250.000+20%3678373160.0002869427866.667+28%2140116160.000+72%2078771398.421+77%1948825623.846+89%
Net Profit Margin--0.1430.142+1%0.048+198%0.063+127%0.080+80%
Operating Margin--0.1430.107+35%0.053+170%0.059+141%0.088+62%
Operating Ratio--0.8570.870-2%0.699+23%0.697+23%0.766+12%
Pb Ratio7.926+20%6.3294.918+29%4.831+31%4.881+30%5.693+11%
Pe Ratio31.483+20%25.14025.2020%67.999-63%112.213-78%84.009-70%
Price Per Share337.500+20%269.500210.233+28%156.800+72%152.305+77%142.785+89%
Price To Free Cash Flow Ratio-69.736-25%-55.686-2.858-95%57.756-196%4.736-1276%16.570-436%
Price To Total Gains Ratio160.996+20%128.558-75.469+159%62.641+105%321.539-60%422.530-70%
Quick Ratio--0.4100.468-12%0.415-1%0.393+4%0.392+5%
Return On Assets--0.0390.034+16%0.015+156%0.015+164%0.018+116%
Return On Equity--0.0640.051+25%0.026+147%0.024+168%0.028+131%
Total Gains Per Share--2.0962.650-21%2.560-18%1.238+69%1.067+96%
Usd Book Value--636338361.600640291680.533-1%502187929.174+27%469862101.358+35%386030409.043+65%
Usd Book Value Change Per Share--0.8721.739-50%2.638-67%0.865+1%0.744+17%
Usd Book Value Per Share--46.62246.912-1%36.794+27%34.425+35%28.283+65%
Usd Dividend Per Share--1.4231.162+23%0.164+766%0.491+190%0.425+235%
Usd Eps--2.9342.415+21%0.630+366%0.693+324%0.753+290%
Usd Free Cash Flow---18081178.600-12617992.567-30%-420852.188-98%-14655611.013-19%-2222380.266-88%
Usd Free Cash Flow Per Share---1.325-0.924-30%-0.031-98%-1.074-19%-0.163-88%
Usd Free Cash Flow To Equity Per Share--0.942-0.678+172%0.499+89%0.001+90824%0.253+273%
Usd Market Cap5043587050.125+20%4027450772.8843141736571.213+28%2343213183.584+72%2276046804.131+77%2133769175.549+89%
Usd Price Per Share369.529+20%295.076230.184+28%171.680+72%166.759+77%156.335+89%
Usd Profit--40050347.10032968533.900+21%12900659.250+210%12193094.532+228%11115389.707+260%
Usd Revenue--279626511.000231831936.200+21%166594235.775+68%149572315.299+87%123581187.535+126%
Usd Total Gains Per Share--2.2952.901-21%2.803-18%1.356+69%1.168+96%
 EOD+5 -3MRQTTM+20 -16YOY+25 -115Y+29 -710Y+26 -10

3.2. Fundamental Score

Let's check the fundamental score of Ypsomed Holding AG based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1531.483
Price to Book Ratio (EOD)Between0-17.926
Net Profit Margin (MRQ)Greater than00.143
Operating Margin (MRQ)Greater than00.143
Quick Ratio (MRQ)Greater than10.410
Current Ratio (MRQ)Greater than10.773
Debt to Asset Ratio (MRQ)Less than10.380
Debt to Equity Ratio (MRQ)Less than10.620
Return on Equity (MRQ)Greater than0.150.064
Return on Assets (MRQ)Greater than0.050.039
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Ypsomed Holding AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.300
Ma 20Greater thanMa 50367.925
Ma 50Greater thanMa 100361.920
Ma 100Greater thanMa 200333.445
OpenGreater thanClose342.000
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CHF. All numbers in thousands.

Summary
Total Assets936,683
Total Liabilities355,499
Total Stockholder Equity573,692
 As reported
Total Liabilities 355,499
Total Stockholder Equity+ 573,692
Total Assets = 936,683

Assets

Total Assets936,683
Total Current Assets249,253
Long-term Assets687,430
Total Current Assets
Cash And Cash Equivalents 36,379
Net Receivables 95,754
Inventory 101,288
Other Current Assets 15,832
Total Current Assets  (as reported)249,253
Total Current Assets  (calculated)249,253
+/-0
Long-term Assets
Property Plant Equipment 397,764
Intangible Assets 256,894
Long-term Assets Other 2,638
Long-term Assets  (as reported)687,430
Long-term Assets  (calculated)657,296
+/- 30,134

Liabilities & Shareholders' Equity

Total Current Liabilities322,278
Long-term Liabilities33,221
Total Stockholder Equity573,692
Total Current Liabilities
Short-term Debt 203,000
Accounts payable 24,599
Other Current Liabilities 61,055
Total Current Liabilities  (as reported)322,278
Total Current Liabilities  (calculated)288,654
+/- 33,624
Long-term Liabilities
Long-term Liabilities Other 22,336
Long-term Liabilities  (as reported)33,221
Long-term Liabilities  (calculated)22,336
+/- 10,885
Total Stockholder Equity
Common Stock193,144
Retained Earnings 216,506
Accumulated Other Comprehensive Income 164,208
Other Stockholders Equity -166
Total Stockholder Equity (as reported)573,692
Total Stockholder Equity (calculated)573,692
+/-0
Other
Capital Stock193,144
Cash and Short Term Investments 36,379
Common Stock Shares Outstanding 13,649
Current Deferred Revenue33,624
Liabilities and Stockholders Equity 936,683
Net Debt 166,621
Net Invested Capital 573,691
Net Working Capital -73,025
Short Long Term Debt Total 203,000



Balance Sheet

Currency in CHF. All numbers in thousands.

 Trend2023-09-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-31
> Total Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
662,010
0
662,208
0
674,632
0
341,238
0
327,272
0
342,055
0
341,793
0
349,252
0
354,528
0
361,766
0
361,211
0
369,438
0
388,871
393,000
392,758
422,000
421,800
440,560
440,560
500,239
500,239
547,225
547,225
587,748
587,748
613,862
613,862
0
674,738
0
715,483
0
717,683
734,594
734,594
756,910
756,910
790,843
790,843
861,879
861,879
936,683
936,683861,879861,879790,843790,843756,910756,910734,594734,594717,6830715,4830674,7380613,862613,862587,748587,748547,225547,225500,239500,239440,560440,560421,800422,000392,758393,000388,8710369,4380361,2110361,7660354,5280349,2520341,7930342,0550327,2720341,2380674,6320662,2080662,010000000000000000000000000000000000
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100,152
0
93,866
0
107,385
0
104,201
0
94,604
0
108,459
0
108,731
0
111,399
0
114,584
0
119,483
0
123,498
0
130,884
0
148,363
152,000
151,592
175,000
175,378
185,098
185,097
218,311
218,311
221,387
221,387
178,789
178,789
176,763
176,763
186,387
186,387
190,344
190,344
185,140
185,141
185,303
185,303
193,584
193,584
192,131
192,131
208,327
208,327
249,253
249,253208,327208,327192,131192,131193,584193,584185,303185,303185,141185,140190,344190,344186,387186,387176,763176,763178,789178,789221,387221,387218,311218,311185,097185,098175,378175,000151,592152,000148,3630130,8840123,4980119,4830114,5840111,3990108,7310108,459094,6040104,2010107,385093,8660100,152000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,065
0
4,758
0
5,022
0
19,264
0
9,735
0
13,264
0
9,613
0
14,908
0
16,164
0
18,259
0
16,243
0
18,751
0
25,507
28,000
27,809
39,000
38,884
35,448
35,448
32,111
32,111
35,018
35,018
12,083
12,083
23,991
23,991
0
13,394
0
22,063
0
19,320
27,625
27,625
17,038
15,859
17,150
17,150
25,224
24,477
36,379
36,37924,47725,22417,15017,15015,85917,03827,62527,62519,320022,063013,394023,99123,99112,08312,08335,01835,01832,11132,11135,44835,44838,88439,00027,80928,00025,507018,751016,243018,259016,164014,90809,613013,26409,735019,26405,02204,75808,065000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,940
0
7,002
0
3,091
2,422
2,422
0
1,179
0
0
0
747
0
07470001,17902,4222,4223,09107,00208,9400000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
46,000
46,000
64,000
64,000
72,560
72,560
98,637
98,637
63,257
63,257
89,848
89,695
73,157
63,891
76,350
76,350
68,905
68,840
72,730
72,663
75,590
75,590
86,986
95,488
81,323
81,323
96,902
109,026
95,754
95,754109,02696,90281,32381,32395,48886,98675,59075,59072,66372,73068,84068,90576,35076,35063,89173,15789,69589,84863,25763,25798,63798,63772,56072,56064,00064,00046,00046,0000000000000000000000000000000000000000000000000000000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
45,287
0
43,051
0
50,787
0
34,554
0
34,722
0
39,551
0
42,545
0
44,000
0
46,189
0
43,586
0
55,474
0
62,958
0
73,761
16,000
72,461
14,000
88,174
11,904
95,656
19,641
126,916
62,463
136,459
13,138
114,294
3,004
90,408
16,745
107,767
15,124
15,124
13,694
13,695
7,787
7,787
10,425
10,672
9,704
13,005
13,444
15,053
15,832
15,83215,05313,44413,0059,70410,67210,4257,7877,78713,69513,69415,12415,124107,76716,74590,4083,004114,29413,138136,45962,463126,91619,64195,65611,90488,17414,00072,46116,00073,761062,958055,474043,586046,189044,000042,545039,551034,722034,554050,787043,051045,287000000000000000000000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
561,858
0
568,342
0
567,247
0
237,037
0
232,668
0
233,596
0
233,062
0
237,853
0
239,944
0
242,283
0
237,713
0
238,554
0
240,508
0
241,166
0
246,422
0
255,463
0
281,928
0
325,838
0
408,959
0
437,099
0
488,351
0
525,139
0
532,543
549,291
549,291
563,327
563,326
565,830
598,712
420,815
653,552
687,430
687,430653,552420,815598,712565,830563,326563,327549,291549,291532,5430525,1390488,3510437,0990408,9590325,8380281,9280255,4630246,4220241,1660240,5080238,5540237,7130242,2830239,9440237,8530233,0620233,5960232,6680237,0370567,2470568,3420561,858000000000000000000000000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
186,273
0
184,703
0
179,052
0
172,660
0
166,361
0
164,333
0
161,686
0
162,366
0
160,437
0
158,003
0
150,946
0
152,791
0
153,752
0
157,009
0
158,615
171,451
171,451
192,314
192,314
236,478
236,478
268,644
268,644
292,148
292,148
309,097
309,097
326,535
326,535
334,379
334,379
337,179
337,179
336,150
327,945
362,447
362,447
387,677
379,587
397,764
397,764379,587387,677362,447362,447327,945336,150337,179337,179334,379334,379326,535326,535309,097309,097292,148292,148268,644268,644236,478236,478192,314192,314171,451171,451158,6150157,0090153,7520152,7910150,9460158,0030160,4370162,3660161,6860164,3330166,3610172,6600179,0520184,7030186,273000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,000
7,000
10,000
10,000
8,961
8,961
10,196
10,196
8,622
8,622
8,723
8,723
9,111
9,111
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000009,1119,1118,7238,7238,6228,62210,19610,1968,9618,96110,00010,0007,0007,0000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
352,327
0
359,085
0
361,544
0
50,374
0
50,191
0
0
0
55,141
0
0
0
61,296
0
0
0
69,007
0
0
0
72,978
0
0
0
73,575
72,474
72,474
8,391
77,139
77,813
77,813
8,250
81,419
86,842
86,842
0
102,516
0
122,286
0
160,728
0
174,734
190,778
190,779
200,747
200,747
30,499
231,738
256,894
256,894231,73830,499200,747200,747190,779190,778174,7340160,7280122,2860102,516086,84286,84281,4198,25077,81377,81377,1398,39172,47472,47473,57500072,97800069,00700061,29600055,14100050,191050,3740361,5440359,0850352,327000000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,576
2,576
71,027
71,027
2,925
2,925
123,342
123,342
48,998
4,049
167,869
167,869
76,153
76,153
159,630
-1
34,730
34,730
-1
-1
32,882
32,882
232,737
31,498
0
031,498232,73732,88232,882-1-134,73034,730-1159,63076,15376,153167,869167,8694,04948,998123,342123,3422,9252,92571,02771,0272,5762,57600000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
124,267
0
126,377
0
136,576
0
113,417
0
109,270
0
124,353
0
124,419
0
129,694
0
126,366
0
126,977
0
120,574
0
119,581
0
121,035
115,000
115,410
120,000
120,005
136,751
136,751
158,697
158,697
170,949
170,949
208,944
208,944
237,908
237,908
0
299,566
0
333,375
0
322,298
350,014
350,014
364,371
356,631
265,150
274,710
258,988
291,570
355,499
355,499291,570258,988274,710265,150356,631364,371350,014350,014322,2980333,3750299,5660237,908237,908208,944208,944170,949170,949158,697158,697136,751136,751120,005120,000115,410115,000121,0350119,5810120,5740126,9770126,3660129,6940124,4190124,3530109,2700113,4170136,5760126,3770124,267000000000000000000000000000000000
   > Total Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
77,953
0
90,057
0
100,742
0
95,608
0
90,895
0
105,673
0
101,367
0
106,412
0
103,037
0
108,162
0
100,628
0
103,990
0
105,325
105,000
104,609
103,000
103,006
121,404
121,404
142,453
142,453
154,059
154,059
187,883
187,883
217,865
217,865
274,987
274,987
308,395
308,395
272,377
272,377
277,833
277,833
237,336
237,336
265,150
265,150
258,988
258,988
322,278
322,278258,988258,988265,150265,150237,336237,336277,833277,833272,377272,377308,395308,395274,987274,987217,865217,865187,883187,883154,059154,059142,453142,453121,404121,404103,006103,000104,609105,000105,3250103,9900100,6280108,1620103,0370106,4120101,3670105,673090,895095,6080100,742090,057077,953000000000000000000000000000000000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
46,500
0
61,000
0
64,500
0
66,500
0
62,500
0
52,000
0
56,000
0
47,000
0
34,000
45,000
35,000
37,000
27,000
52,000
42,000
59,000
49,000
0
83,000
0
112,000
0
150,980
0
182,999
0
210,000
0
182,500
0
204,500
157,000
157,000
0
144,000
0
157,000
203,000
203,000157,0000144,0000157,000157,000204,5000182,5000210,0000182,9990150,9800112,000083,000049,00059,00042,00052,00027,00037,00035,00045,00034,000047,000056,000052,000062,500066,500064,500061,000046,50000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
45,000
45,000
37,000
37,000
52,000
52,000
59,000
59,000
0
0
0
112,000
0
150,980
0
182,999
0
210,000
0
182,500
0
0
0
157,000
0
0
0
157,000
0
0157,000000157,000000182,5000210,0000182,9990150,9800112,00000059,00059,00052,00052,00037,00037,00045,00045,0000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,292
0
13,012
0
13,080
0
13,584
0
13,461
0
18,587
0
16,659
0
16,774
0
15,928
0
21,587
0
15,484
0
15,944
0
19,968
17,000
16,655
22,000
21,956
27,433
27,433
31,916
31,916
17,810
17,810
19,348
19,348
17,349
17,349
24,044
24,044
21,221
21,221
34,553
34,553
19,762
19,762
17,386
17,386
20,701
20,701
19,620
19,620
24,599
24,59919,62019,62020,70120,70117,38617,38619,76219,76234,55334,55321,22121,22124,04424,04417,34917,34919,34819,34817,81017,81031,91631,91627,43327,43321,95622,00016,65517,00019,968015,944015,484021,587015,928016,774016,659018,587013,461013,584013,080013,012013,292000000000000000000000000000000000
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
64,661
0
77,045
0
87,662
0
82,024
0
30,934
0
26,086
0
20,208
0
23,138
0
24,609
0
34,575
0
29,144
0
41,046
0
51,357
23,000
52,954
25,000
54,050
20,781
51,971
28,815
61,537
22,004
53,249
24,778
56,535
22,256
49,536
41,266
67,944
46,819
-2
26,041
54,084
258,071
258,071
62,950
43,406
244,449
83,946
239,368
58,450
61,055
61,05558,450239,36883,946244,44943,40662,950258,071258,07154,08426,041-246,81967,94441,26649,53622,25656,53524,77853,24922,00461,53728,81551,97120,78154,05025,00052,95423,00051,357041,046029,144034,575024,609023,138020,208026,086030,934082,024087,662077,045064,661000000000000000000000000000000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
46,314
0
36,320
0
35,834
0
17,809
0
18,375
0
18,680
0
23,052
0
23,282
0
23,329
0
18,815
0
19,946
0
15,591
0
15,710
0
10,801
0
16,999
0
15,347
0
16,244
0
16,890
0
21,061
0
20,043
0
24,579
0
24,980
0
49,921
72,181
72,181
127,035
119,295
0
9,560
0
32,582
33,221
33,22132,58209,5600119,295127,03572,18172,18149,921024,980024,579020,043021,061016,890016,244015,347016,999010,801015,710015,591019,946018,815023,329023,282023,052018,680018,375017,809035,834036,320046,314000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,000
0
10,000
0
10,000
0
32,500
0
55,000
0
110,000
0
0
0
0
0
00000110,000055,000032,500010,000010,000010,00000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,347
5,347
6,244
6,244
6,890
6,890
11,061
11,061
10,043
10,043
14,579
14,579
14,980
14,980
17,421
17,421
17,180
17,180
17,034
17,034
16,653
16,653
0
0
0
00016,65316,65317,03417,03417,18017,18017,42117,42114,98014,98014,57914,57910,04310,04311,06111,0616,8906,8906,2446,2445,3475,34700000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
68,000
68,000
0
0
68,748
68,748
0
0
73,169
73,169
0
0
91,316
91,316
0
0
124,862
124,862
0
0
156,537
156,537
0
0
201,239
201,239
0
0201,239201,23900156,537156,53700124,862124,8620091,31691,3160073,16973,1690068,74868,7480068,00068,000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
537,743
0
535,831
0
538,056
0
227,821
0
218,003
0
217,702
0
217,374
0
219,558
0
228,162
0
234,789
0
240,637
0
249,857
0
267,836
0
277,348
0
301,796
303,809
303,809
341,542
341,542
376,276
376,276
378,804
378,804
375,954
375,954
0
375,172
0
382,108
0
395,385
384,580
384,580
392,539
392,540
659,895
509,040
695,731
562,333
573,692
573,692562,333695,731509,040659,895392,540392,539384,580384,580395,3850382,1080375,1720375,954375,954378,804378,804376,276376,276341,542341,542303,809303,809301,7960277,3480267,8360249,8570240,6370234,7890228,1620219,5580217,3740217,7020218,0030227,8210538,0560535,8310537,743000000000000000000000000000000000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
182,156
0
178,994
0
178,994
0
178,994
0
178,994
0
178,994
0
178,994
0
178,994
0
178,994
0
178,994
0
178,994
0
178,994
0
178,994
179,000
178,994
179,000
178,994
178,994
178,994
178,994
178,994
178,994
178,994
178,994
178,994
178,994
178,994
178,994
178,994
178,994
178,994
178,994
178,994
178,994
178,994
178,994
178,994
193,144
193,144
193,144
193,144
193,144
193,144193,144193,144193,144193,144178,994178,994178,994178,994178,994178,994178,994178,994178,994178,994178,994178,994178,994178,994178,994178,994178,994178,994178,994178,994178,994179,000178,994179,000178,9940178,9940178,9940178,9940178,9940178,9940178,9940178,9940178,9940178,9940178,9940178,9940182,156000000000000000000000000000000000
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-167,878
0
0
0
-171,651
0
0
0
-184,195
0
0
0
-181,753
0
0
0
-189,023
0
0
0
-205,400
0
0
0
-214,763
0
0
0
-225,953
0
0
0
-234,760
0
0
0
-252,509
0
0
0
-277,109
0
0
0
-304,227
0
0
0
81,030
0
172,036
0
180,555
164,208
164,208180,5550172,036081,030000-304,227000-277,109000-252,509000-234,760000-225,953000-214,763000-205,400000-189,023000-181,753000-184,195000-171,651000-167,878000000000000000000000000000000000
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000-9560-9560-6,5950-6,5950-6,59500000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
523,465
0
356,837
0
530,713
0
-142,098
0
31,365
0
-155,168
0
26,648
0
-157,521
0
31,098
0
-160,396
0
40,555
0
-170,836
0
41,305
0
-186,375
0
40,208
-196,010
-207,135
-191,464
36,701
-212,818
-219,413
-214,338
31,576
-224,791
-231,386
-229,422
41,092
-227,754
-234,349
-222,287
80,983
-233,839
-233,839
-241,862
0
-659,895
-659,895
-695,731
-167
-166
-166-167-695,731-659,895-659,8950-241,862-233,839-233,83980,983-222,287-234,349-227,75441,092-229,422-231,386-224,79131,576-214,338-219,413-212,81836,701-191,464-207,135-196,01040,2080-186,375041,3050-170,836040,5550-160,396031,0980-157,521026,6480-155,168031,3650-142,0980530,7130356,8370523,465000000000000000000000000000000000



Balance Sheet

Currency in CHF. All numbers in thousands.




Cash Flow

Currency in CHF. All numbers in thousands.




Income Statement

Currency in CHF. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue497,460
Cost of Revenue-356,869
Gross Profit140,591140,591
 
Operating Income (+$)
Gross Profit140,591
Operating Expense-103,293
Operating Income37,29837,298
 
Operating Expense (+$)
Research Development28,953
Selling General Administrative26,219
Selling And Marketing Expenses77,074
Operating Expense103,293132,246
 
Net Interest Income (+$)
Interest Income23
Interest Expense-2,310
Other Finance Cost-0
Net Interest Income-2,287
 
Pretax Income (+$)
Operating Income37,298
Net Interest Income-2,287
Other Non-Operating Income Expenses0
Income Before Tax (EBT)56,63717,959
EBIT - interestExpense = 34,988
56,637
53,585
Interest Expense2,310
Earnings Before Interest and Taxes (EBIT)37,29858,947
Earnings Before Interest and Taxes (EBITDA)115,858
 
After tax Income (+$)
Income Before Tax56,637
Tax Provision-5,362
Net Income From Continuing Ops51,27551,275
Net Income51,275
Net Income Applicable To Common Shares51,275
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses460,162
Total Other Income/Expenses Net19,3392,287
 

Technical Analysis of Ypsomed
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ypsomed. The general trend of Ypsomed is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ypsomed's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ypsomed Holding AG.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 340.50 < 352.50 < 389.50.

The bearish price targets are: 327.50 > 313.00 > 295.00.

Tweet this
Ypsomed Holding AG Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ypsomed Holding AG. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ypsomed Holding AG Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ypsomed Holding AG. The current macd is -1.91902536.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ypsomed price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Ypsomed. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Ypsomed price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Ypsomed Holding AG Daily Moving Average Convergence/Divergence (MACD) ChartYpsomed Holding AG Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ypsomed Holding AG. The current adx is 21.17.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Ypsomed shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Ypsomed Holding AG Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ypsomed Holding AG. The current sar is 379.38.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Ypsomed Holding AG Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ypsomed Holding AG. The current rsi is 33.30. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Ypsomed Holding AG Daily Relative Strength Index (RSI) ChartYpsomed Holding AG Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ypsomed Holding AG. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ypsomed price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Ypsomed Holding AG Daily Stochastic Oscillator ChartYpsomed Holding AG Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ypsomed Holding AG. The current cci is -197.58375461.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Ypsomed Holding AG Daily Commodity Channel Index (CCI) ChartYpsomed Holding AG Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ypsomed Holding AG. The current cmo is -49.98647838.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Ypsomed Holding AG Daily Chande Momentum Oscillator (CMO) ChartYpsomed Holding AG Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ypsomed Holding AG. The current willr is -94.54545455.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Ypsomed Holding AG Daily Williams %R ChartYpsomed Holding AG Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Ypsomed Holding AG.

Ypsomed Holding AG Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ypsomed Holding AG. The current atr is 11.93.

Ypsomed Holding AG Daily Average True Range (ATR) ChartYpsomed Holding AG Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ypsomed Holding AG. The current obv is 796,723.

Ypsomed Holding AG Daily On-Balance Volume (OBV) ChartYpsomed Holding AG Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ypsomed Holding AG. The current mfi is 38.45.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Ypsomed Holding AG Daily Money Flow Index (MFI) ChartYpsomed Holding AG Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ypsomed Holding AG.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-15BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Ypsomed Holding AG Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ypsomed Holding AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.300
Ma 20Greater thanMa 50367.925
Ma 50Greater thanMa 100361.920
Ma 100Greater thanMa 200333.445
OpenGreater thanClose342.000
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Ypsomed with someone you think should read this too:
  • Are you bullish or bearish on Ypsomed? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ypsomed? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ypsomed Holding AG

I send you an email if I find something interesting about Ypsomed Holding AG.


Comments

How you think about this?

Leave a comment

Stay informed about Ypsomed Holding AG.

Receive notifications about Ypsomed Holding AG in your mailbox!